Recent News

• 09.04.2025 - Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
• 08.25.2025 - Climb Bio to Present at Upcoming September 2025 Investor Conferences
• 08.12.2025 - Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 06.18.2025 - Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Recent Filings

• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - EX-99.1 EX-99.1
• 08.12.2025 - 8-K Current report
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.23.2025 - 3 Initial statement of beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 3 Initial statement of beneficial ownership of securities